While the cacao market has stabilized some since the volatility of recent years, the El Niño is expected to hit next year’s cacao harvest, which is already facing disease pressures that are cutting into yields. However, gene-editing is providing a way to produce stronger cocoa plants, which leads to more resilient supply chains, Ido Margalit, CEO of BetterSeeds and AgroNetica, told AgNavigator.
“With the El Niño and the ensuing climate changes, we’re going to see the fluctuations in West Africa, which supplies 70% of the cacao. They’re already forecasting a decrease of 30-40% of the cacao yield for the next season. So, already the chocolate industry will be stressed because they’ve never really fully recovered from the big gap from two years ago,” Margalit elaborated.
Boosting cacao yields with gene-editing
Founded in 2017, Israel-headquartered BetterSeeds developed a second-generation CRISPR technology that silences genes in a plant to produce desirable traits. The company operates a US subsidiary called AgroNetica that is focused on commercializing Phytophthora-resistant cacao and a separate one for hypoallergenic peanuts.
Phytophthora, or black pod disease, is a mold-based disease that results in 20-30% of the cacao loss globally. AgroNetica’s transgene-free gene-edited cacao experienced 42% less disease damage following Phytophthora infections, according to controlled disease assays from researchers at Penn State University’s Department of Plant Science.
Additionally, AgroNetica plans to deliver cacao traits that reduce heavy metal uptake and eliminate caffeine content in specific varieties.
With these results and regulatory changes, AgroNetica is attracting the attention of four major chocolate companies. Initially, when the gene-editing company approached these food companies, they wanted proof that the technology worked and were unsure of the EU regulatory climate on genetically modified organisms (GMOs).
The company now has propagation material (i.e. saplings) that proves the technology works, and the regulatory climate in the EU has changed, Margalit noted. Companies can use the cacao tree saplings to produce millions more trees with the traits to defend against the disease or other beneficial traits, he added.
“About three months ago, the EU voted in favor of the new regulations that pretty much look the same as in Canada, India, China, and the U.S. If you used CRISPR and you silenced a gene and you did not insert any form of genetic material, the review process is very fast. It takes weeks and it gets approved, and no labeling is needed, and the variety is deemed like it was conventionally bred,” Margalit elaborated.
What’s next for AgroNetica?
AgroNetica plans to integrate its full suite of traits into cacao plants, applying the tech to a range of varieties. The gene-editing company will bridge its business’ development and revenue-generating phases through another funding round, Margalit said. BetterSeeds and its subsidiaries has raised $24 million to date, he added.
“We aim to raise at the minimum of around $15 million. That money should be substantial enough to enable us to reach the initial revenue. Hopefully, by 2028, this revenue will already fund the operation of the company, and no more additional funding will be needed,” he elaborated.



